Provided by Tiger Fintech (Singapore) Pte. Ltd.

Seres Therapeutics

0.6898
+0.05148.05%
Post-market: 0.6600-0.0298-4.32%19:11 EDT
Volume:812.35K
Turnover:548.49K
Market Cap:117.78M
PE:-3.93
High:0.6900
Open:0.6500
Low:0.6400
Close:0.6384
Loading ...

Seres reports Q3 EPS from continuing operations (33c), consensus (24c)

TIPRANKS
·
14 Nov 2024

Seres Therapeutics (MCRB) Gets a Buy from TD Cowen

TIPRANKS
·
13 Nov 2024

Seres Therapeutics Inc reports results for the quarter - Earnings Summary

Reuters
·
13 Nov 2024

BRIEF-Seres Therapeutics Reports Q3 2024 Financial Results And Provides Business Updates

Reuters
·
13 Nov 2024

Seres Therapeutics: Q3 Earnings Snapshot

Associated Press Finance
·
13 Nov 2024

Seres Therapeutics Q3 2024 GAAP EPS $(0.33) Misses $(0.25) Estimate, Seres Had $66.8M In Cash And Cash Equivalents, That Is Expected To Fund Operations Into The Fourth Quarter Of 2025

Benzinga
·
13 Nov 2024

Seres Therapeutics Inc: Co Expects to Fund Operations Into Q4 2025

THOMSON REUTERS
·
13 Nov 2024

Seres Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

THOMSON REUTERS
·
13 Nov 2024

Seres Therapeutics Q3 EPS USD 0.58

THOMSON REUTERS
·
13 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 Nov 2024

Seres Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
11 Nov 2024

BUZZ-China's Zhongsheng hits nearly 12-month high; Jefferies lifts PT after Seres deal

Reuters
·
11 Nov 2024

Seres Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
29 Oct 2024

Institutions along with retail investors who hold considerable shares inSeres Therapeutics, Inc. (NASDAQ:MCRB) come under pressure; lose 17% of holdings value

Simply Wall St.
·
26 Oct 2024

JPMorgan Downgrades Seres Therapeutics to Underweight

MT Newswires Live
·
24 Oct 2024

Seres Therapeutics Cut to Underweight From Neutral by JP Morgan

Dow Jones
·
24 Oct 2024